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ABSTRACT 
This thesis serves to introduce a new point-of-care testing device capable of providing 
spectrometric data for solid and liquid phase samples.  A custom cradle was developed to maintain 
optical alignment allowing for the diffraction, and therefore spectrometric analysis, of light 
transmitted either directly through a sample or via an intermediary optical biosensor.  
Demonstration of the instrument is provided with both an enzyme-linked immunosorbent assay 
(ELISA) and a photonic-crystal (PC)-based investigation of biomolecular adsorption.  ELISA 
analysis is completed on both human interleukin-6, an important diagnostic cancer biomarker, and 
Ara h 1, one of the principle peanut proteins responsible for allergic reactions.  PC-based sensing 
was completed with a Protein A-immunoglobulin G interaction with a .009 nm accuracy.  All of 
these demonstrations were completed at physiologically-relevant concentrations, and as such, 
serve as proof-of-concept for two separate modalities of a smartphone-based spectrometric optical 
biosensor.  In the future, such a sensor has the potential to provide a low-cost, point-of-care 
diagnostic device that is inherently robust, user-friendly, cloud-connected, and suited for use in 
remote sensing applications.   
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CHAPTER 1: INTRODUCTION 
Medical diagnostics has grown into a burgeoning 48.5 billion dollar market in the United 
States alone, with significant growth expected due to the implementation of the Affordable Care 
Act.1  Combined with the anticipated shortage in clinical physicians,2 the importance of providing 
accessible point-of-care testing (POCT) technologies is rapidly increasing so as to facilitate the 
dissemination of diagnostic capabilities from the traditional hospital laboratory setting to the 
community clinic.   
On a global scale, there is an echoing of this need for simple POCT technologies.  The 
existing medical infrastructure present in the US is one of the most developed in the world; in 
many other, especially less developed, nations, a majority of clinical testing is completed at the 
secondary and tertiary levels.3 The importance of medical laboratory testing has been neglected in 
many of the funding initiatives for healthcare systems on a global scale,4, 5 and POCT provides a 
unique answer to this critical need for diagnostics that is implementable in tandem with the slow 
process of building out national laboratory infrastructure. 
Recent developments in POCT have been widely demonstrated across multiple clinical 
fields, and in certain cases such as diabetes testing, have quickly moved into the realm of every-
day life.  POCT is expected to extend to important applications beyond human health diagnostics, 
including food safety, food processing, quality control, water quality monitoring, animal 
diagnostics, and pathogen detection.6-9   
 An important prerequisite for the widespread adoption of POCT is the availability of 
detection instruments that are inexpensive, portable, and able to share data wirelessly over the 
internet.  Due to the rapid development of computational, communicational, and sensing 
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capabilities of smartphones since the introduction of the iPhone in 2007, these devices have 
become more like personal computers with integrated cameras, geolocation capabilities, and 
access to the internet.  Since 2011, over 478 million smartphones are sold annually, with that 
number expected to double in the next 4 years,10 making them a nearly ubiquitous tool that can be 
adapted to performing POCT.   
A variety of input methods exist on contemporary smartphones: microphones, cameras, 
accelerometers, touchscreens, GPS, and even fingerprint scanners.  While designed for specific 
usage cases, many of these input methods have been successfully utilized to sense a variety of 
interesting phenomena: fall detection in the elderly via accelerometer,11 aggressive driving 
behavior via GPS,12 and a variety of fitness metrics catalogued by a variety of downloadable 
applications, including Gymskill, Spirosmart, and Balance.13  One of the most rapidly improved 
and consumer-visible sensors present is the rear-facing camera, which has similarly been used for 
a variety of diagnostic purposes.  Recent examples include attachments that enable smartphones 
to serve as stethoscopes,14 ultrasound probes,15 as well as optical16 and fluorescent microscopes.17  
1.1 Scope 
The following studies were completed as a proof-of-concept for two different optical 
sensing modalities.  There is significant work that must be done to transfer the developed 
technology to a truly point-of-care device that can be of use in a clinical setting.  This work is 
meant to compliment other work that has been completed in the realms of microfluidics and sample 
collection.  Additionally, the instruments created as part of this work were fabricated as prototypes 
with off-the-shelf components.  A custom-fabricated system would provide several advantages, 
but was beyond the cost and time considerations of this work.  As a proof-of-concept, this is 
believed to be the first demonstration of spectroscopic assays being performed on a smartphone 
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platform.  As a mainstay of diagnostic medicine, spectroscopy poses an important measurement 
technique to be translated to a point-of-care device.  Finally it should be noted that the data 
processing and analysis was completed off-device via Matlab.  As a more user-friendly and broadly 
applicable software package, it has provided significant advantages over iOS or Android 
programming environments for the development of the technology and the demonstration of proof-
of-concept.  While future iterations of these sensing systems will likely be completed via onboard 
software, this was not a focus of this work. 
1.2 Overview 
 This thesis aims to investigate two fundamental optical biosensing modalities: the 
absorption-based measurement of enzyme-linked immunosorbent assays (ELISAs) and the label-
free measurement of biomolecular adsorption on photonic crystal (PC) sensors.  First, an overview 
of ELISA testing will be given, and a survey of contemporary attempts to bring the technology out 
of the traditional laboratory setting will be completed.  Then, using the developed biosensing 
platform, a demonstration of the system will be completed using a cancer biomarker, human 
interleukin 6 (IL-6), and a peanut allergen, Ara h 1.  Then, the underpinnings of photonic crystal-
based detection will be discussed, followed by a summary of the practical experiments that have 
been demonstrated thus far on a smartphone-based platform.  A brief discussion of other optical 
sensing modalities amenable with the current platform will be completed, followed by a look 
forward toward a single platform capable of performing all of these basic optical techniques 
without augmentation.  Finally future directions and anticipated challenges will be discussed. 
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CHAPTER 2: DESIGN OF A SMARTPHONE BIOSENSOR 
2.1 Instrument Design and Fabrication 
 The instrument cradle was designed to interface with an iPhone 4 (800 MHz ARM 
Cortex A8, Omnivison OV5653 5MP BSI CMOS sensor with f/2.4, 5 element lens; Apple 
Inc.) by using the onboard, rear-facing camera as a digital light detector.  A custom cradle 
fabricated from anodized aluminum was designed to align the necessary optics with the 
phone camera.18 This cradle allows for the precise alignment of the optical path with the 
aperture of the smartphone camera, while maintaining full utility of the screen, enabling 
the camera to function as a spectrometer. The main optical path is comprised of a square 
channel with two rubber bands along its length so that optical components can be moved 
along the optical axis, but will maintain proper centering and not move freely on their own.  
For these experiments, two configurations were used, one for solid-phase PC-based 
measurements and the other for liquid-phase immunoassays, as shown schematically in 
Figure 1. 
 For the solid-phase system, a broadband light source (150 W halogen fiber optic 
high intensity illuminator; Cole Parmer) is used to illuminate a 100 micron pinhole at the 
end of the channel.  Upon entry, light is collimated (focal length, f=75mm) and linearly 
polarized to align the electric field with the PC grating. At the PC surface, the characteristic 
narrowband reflection occurs, and the remaining transmitted light is focused to a line via a 
cylindrical lens (f=50 mm) through the smartphone aperture and onto the CMOS sensor.  
Between the cylindrical lens and the smartphone is a diffraction grating (1200 lines/mm), 
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which disperses light in one direction generating a spectral dimension on the resulting 
captured image.   
Optical Cradle
Optical Cradle
A)
B)
Figure 1. Schematic Drawings of Smartphone Biosensing Attachments for A) Absorption measurements for 
ELISA analysis and B) for PC-based label-free detection of biomolecular attachment.  To align the first order 
diffraction pattern with the CMOS sensor of the smartphone, the optical path is at an angle of approximately 47º.  In 
both systems, the pinhole serves to optically isolate the internal optical path and to maximize spectral resolution, as 
the diffracted spectrum is convoluted with the apparent light source, just as a slit does on a traditional spectrometer. 
Inset: Photograph of smartphone cradle in use.  
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 For the liquid-phase system, the same broadband light source is used to illuminate 
the sample cuvette.  Light that is not absorbed by the sample is collected by a 1 mm diameter 
optical fiber and relayed to a 0.1 mm diameter pinhole at the end of the optical channel.  
Light that enters the optical channel is similarly collimated (f=75mm), focused to a line by 
a cylindrical lens (f = 50 mm), and diffracted (1200 grooves/mm) as in the solid-phase 
instrument.   
 In both cases, the wavelength components of the light are separated by the 
diffraction grating, which disperses the light onto the pixels of the camera.  Illumination 
from the lamp is observed in the resulting camera image as a bright, rainbow band 
appearing near the center of the screen on the smartphone.  Although the iPhone4 camera 
image sensor has a total of 5 megapixels (2592 x 1936), the spectrum band covers 
approximately 750 pixels in the dispersive direction and it is roughly 100 pixels wide. 
Assuming a focal length of the iPhone4 lens of 3.85 mm, the wavelength separation 
between adjacent pixels in the spectral direction will be 0.334 nm/pixel.  Due to the spectral 
responsivity of the Si-based sensor and internal infrared cutoff filters within the camera 
optics, the range of wavelengths which may be observed by the system extends from 
approximately 400 to 700 nm.   
2.2 Use of the Smartphone Instrument 
 Before introduction to the cradle, the iPhone was prepared by first locking the focus 
and exposure of the native camera application by focusing on a point sufficiently far away 
in a dark room or hallway to focus the camera at an infinite distance in a low-light setting. 
The phone was then placed in the cradle, and a broadband illumination source was turned 
on at the end of the optical path.  The phone was aligned using adjustment knobs to achieve 
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an x-y positioning providing a centered image of a broadband spectrum on the smartphone 
display.  The broadband light source used allowed for the manual manipulation of intensity, 
which was adjusted to maximize the dynamic range of the sensor for each of the two 
modalities.  For every measurement step, five consecutive images were captured using the 
native iPhone camera application and averaged to account for variations arising from the 
camera hardware and sensor noise.  Red and green laser pointers (λ = 656.26 nm and λ = 
532.10 nm, respectively) measured with a spectrometer (USB2000+; Ocean Optics) were 
imaged using the smartphone system to provide reference wavelengths for calibration of 
the pixel to wavelength conversion.  
2.3 Image Processing and Wavelength Calibration 
Post-processing scripts were written in Matlab to convert raw images into absorption 
spectra.  Once images are uploaded to a PC, auto-thresholding is performed to crop non-data pixels 
from analysis by removing pixels with zero intensity, which yields a reduction of the image to a ~ 
1100 x 100 block of pixels.  The intensity of pixels in the non-spectral direction is averaged to 
yield a one-dimensional vector representation of the spectra.  
For both label-based and label-free modalities the data of interest lies in the non-transmitted 
light: either the light absorbed by the liquid sample or the resonantly reflected resonant peak of the 
PC.  The non-uniformity of both the red, green, and blue (RGB) color filters and the broadband 
illumination source across the visible wavelengths requires a broadband response be defined 
(Figure 2).  For each assay run, a blank consisting of aqueous solution for liquid-phase or air for 
solid phase is measured.  The resulting RGB responses are recorded, and all other analyte samples 
are subtracted from the blanked RGB channels.  To adjust for differences in RGB channel 
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intensity, each channel is individually normalized to unity to provide a near-uniform spectral 
response.   
Pixel values are converted to wavelength values using a linear approximation via known 
pixel indices calculated by illuminating the pinhole with red and green laser pointers of known 
wavelength.  The laser emission profiles are fit with a 4th order polynomial curve to determine the 
precise pixel index of each laser, and are then used to calculate the pixel-to-wavelength conversion, 
found in this case to be 0.334 nm/pixel.   
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Figure 2. Background spectra and calibration lasers.  Nonuniform transmission is observed for the brightfield light 
source when imaged by the iPhone as a result of the RGB filter responses.  While broadband transmission must be 
corrected for via normalization, laser peaks display a high similarity between the spectrometer and the smartphone 
setup.  Using the known wavelengths of these lasers, the rest of the spectrum is interpolated linearly. 
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CHAPTER 3: QUANTIFICATION OF AN ENZYME-LINKED 
IMMUNOSORBENT ASSAY WITH A SMARTPHONE BIOSENSOR 
3.1 Rationale 
 Since its introduction 40 years ago, ELISA has become one of the most widely 
adaptable tools for biological assays, allowing for the rapid quantification of proteins and 
antibodies for diseases ranging from HIV to cancer, yielding over 40,000 new articles 
involving the technology annually.19   
 An ELISA test is completed by immobilizing primary antibodies that possess an 
affinity for a specific biomolecule of interest onto a surface (usually a 96-well microplate).  
Next, the biomolecule of interest is introduced to the sensor surface where it will be bound 
by the immobilized antibody.  A secondary antibody, also complimentary to the molecule 
of interest, is conjugated to an enzyme and introduced to the sensor surface after a thorough 
washing to remove unbound molecules of interest.  These secondary antibodies will only 
bind to successfully captured molecules of interest.  Finally after another series of washes, 
a chromogen, or color-generating compound, is introduced.  The enzyme present on the 
secondary antibody cleaves a peptide on the chromogen, which causes it to undergo a shift 
Primary Antibody
Molecule of Interest
Secondary Antibody Chromogen
Enzyme Conjugate
Figure 3. Schematic of an ELISA Procedure. On a biosensor, immobilized antibody binds to a molecule of interest, 
which is then targeted by a secondary antibody.  The enzyme bound to this antibody catalyzes a color change of the 
chromogen, yielding a visible color in the solution which can then be quantified via spectroscopy.  
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in its absorption spectrum to the visible range.  After the optical absorptions of standards 
at known concentrations are used to obtain a calibration curve, the concentrations of an 
analyte within a test sample may be accurately determined via interpolation.   
 Here we demonstrate the use of a smartphone to perform the readout and 
quantification of any ELISA assay and compare results with those obtained from a 
conventional laboratory ELISA microplate reader for two representative biomarkers.  First, 
we demonstrate smartphone-based detection of a clinical biomolecule used for human 
disease diagnostics, IL-6.  Second, we demonstrate detection of a peanut allergen, Ara h 1, 
in the context of a food safety application.  Together, these biomarkers illustrate both the 
immediate utility and broad applicability of smartphone-based ELISA.   
 While there have been successful demonstrations of simplifying liquid handling 
steps20-22 and both macro- and microfluidic sample collection techniques amenable to 
POCT,23-26 high quality spectroscopic instruments have yet to be developed for on-site 
analysis.  By providing a spectroscopic reader for ELISA tests that is integrated with a 
mobile communication device, this technology can be used with the myriad of existing, 
well-studied ELISA procedures that have been well characterized for wavelength-specific 
analysis.  Combined with approaches for microfluidic-based automation of sample 
preparation procedures, the detection instrument presented here opens up the possibility of 
transferring ELISA-type tests to other fields requiring point of care analysis, such as quality 
control validation and agricultural monitoring. In this chapter we will demonstrate the 
comparative robustness and sensitivity of a smartphone-based ELISA reader, and pose a 
method for further increased sensitivity via use of integrative spectral measurement. 
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3.2 Comparison to Other Research 
3.2.1 Other POCT Immunoassays 
 The Cunningham lab is not unique in identifying the potential impact that a POCT device 
capable of performing immunoassays might have.  POCT immunoassay have been around for 
many years, and are readily identifiable as part of everyday life.  The most basic and prevalent 
form of POCT ELISA procedures would likely be a standard pregnancy test for human chorionic 
gonadotropin (hCG).  These tests are completed on a paper membrane, and the colorimetric output 
is observed as a binary readout via visual comparison with a control band.  More advanced versions 
of ELISA as POCT have been demonstrated for a variety of conditions including tuberculosis,27 
HIV,28 and Giardia infection.29  While positive/negative results are acceptable for some types of 
diagnostic situations, often quantitative characterization of the amount of biological analyte is 
important within a specified range.   
To this end, several different approaches have been taken. Paper-based microfluidic ELISA 
tests were demonstrated by the Whitesides group in 2004 that provide a quantitative measurement 
system based upon single-wavelength absorption.30  This set of experiments is widely credited as 
the birth of paper microfluidics, a growing area of research for low-cost diagnostics.  Aside from 
the custom-built illumination/sensor system used in that work, the most prevalent method for 
quantitative POCT ELISA measurement uses either a CMOS or CCD to directly image solutions, 
which has recently been shown to be successful on a smartphone platform.31-34 
3.2.2 The Importance of Spectroscopy 
Systems such as these use various RGB color image weighting techniques to analyze 
concentrations of biological molecules of interest and therefore do not provide the spectrometric 
data required to perform a wavelength-based ELISA test.   CMOS sensors, like those found in 
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most smartphone devices, are wavelength-independent photon collectors that convert photons into 
RGB pixels via physical filters.  These filters are comprised of colored dyes that each have both 
their own spectral response35 and an additional infrared cutoff filter with a response that provides 
a sharp cutoff that can vary among batches of identical cameras by 10 nm.36  In such a system, 
light intensity and color are intrinsically intertwined as they both rely on the number of photons 
captured by the RGB pixels compared with the number captured by those adjacent to them. 
Spectrometers have been a cornerstone of modern analytical chemistry.  The Beckman DU 
Spectrophotometer surpassed its contemporaries in popularity rapidly upon its invention, due 
largely to its increased spectral resolution across the entire range of measured wavelengths.  They 
present the standard laboratory tool for the measurement of a variety of experiments as they can 
provide wavelength-specific absorption information.  The peaks at which a substance absorbs light 
the most correspond to chemical bonds and interactions at the molecular level, and can be used to 
identify specific components of a mixture.  By dispersing the spectrum of absorbed light along one 
of the CMOS camera dimensions, we are able to decouple the wavelength from intensity and 
thereby determine the wavelength-specific absorbance of samples.  This enables the accurate 
analysis of ELISA tests in a way that is immune to polychromatic spectral absorption variation. 
3.3 Quantification of Absorption-Based Measurements 
 For this experiment, as the entirety of chromogenic spectral data for 3,3’,5,5’ 
trimethylbenzidine (TMB) tests is captured solely in the blue channel of the RGB data, red and 
green channels are omitted from further calculation for ELISA-based measurements.  To generate 
absorption spectra, converted vector forms of the data were subtracted from those of a blank 
comprised of deionized (DI) water, and normalized to the RGB response of the sensor when 
illuminated without sample or cuvette present in the optical path. 
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 To best compare the smartphone measurement sensitivity with that of a 
commercially available microplate reader, absorption values at λ = 450 nm are interpolated 
from calibrated spectra.  In addition, recognizing the potential value of the full spectral data 
for each sample, we calculate the integrative absorption from 410 < λ < 500 nm (Figure 4).  
Finally, the ELISA microplate reader data is imported from the instrument, appropriately 
normalized with respect to the blank, and averaged across replicates.   
 For each measurement method, the absorption as a function of concentration for the 
calibration standards is fit to a four parameter logistic regression model based upon a 
sigmoidal response curve governed by  
 𝐹(𝑥) = 𝐷 +
𝐴−𝐷
1+(
𝑥
𝐶
)
𝐵 (Eq. 3.1) 
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Figure 4. Example of Wavelength-Normalized Spectra Generated from Camera Images with Peanut Allergen 
Ara h 1.  Five independent smartphone images were averaged, then normalized to a blank.  Using lasers of known 
wavelength, images were converted to wavelength-dependent spectral absorbances.  Five concentrations of peanut 
allergen Ara h 1 are present to illustrate the difference in absorption characteristics.  The dashed line at λ=450 nm 
represents the single wavelength at which conventional ELISA measurements are taken using a microplate reader. 
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where A is the minimum asymptote, B is the Hill’s slope, C is the inflection point, and D 
is the maximum asymptote.  While Beer-Lambert relations are often used to characterize 
absorption-based measurements, this logistic model was selected both on the 
recommendations of the assay protocols and to account for sensor saturation effects and 
polychromaticity for integrative absorption measurements.37 Limits of detection are 
calculated as three standard deviations above the average zero-concentration value for each 
measurement method. 
3.4 Human Interleukin 6 Quantification 
 Human Interleukin-6 (IL-6) is an important cytokine involved in the signaling 
cascade for the pro-inflammatory activation of B-cells following T-cell activation due to 
an antigen-mediated immune response.  Elevated expression of IL-6 in serum samples has 
been demonstrated as an important indicator in conditions ranging from diabetes to 
postoperative surgical stress.38-40 Additionally, IL-6 has been shown to be a relevant cancer 
biomarker important for the tracking, classification, and prognosis of various cancers 
including breast, hepatic, prostate, and renal varieties.41-44 
 A commercially available ELISA kit was purchased (Invitrogen) for the 
quantification of human IL-6.  Lyophilized IL-6 was reconstituted in standard diluent 
buffer, and serially diluted to concentrations of 512, 128, 32, 8, 2, 0.5 and 0.125 pg/mL.  
Standards were added to pre-prepared wells with immobilized anti-IL-6 antibodies in 
replicate (n=6).  A blank well was incubated with only diluent buffer.  Biotinylated anti-
IL-6 antibody was added to each well, and the solutions were allowed to incubate, covered, 
for 2 hours at room temperature on an orbital shaker (100 rpm).  Solutions were removed, 
and the wells were rinsed (4x) with the provided wash solution, per assay instructions.  
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Streptavidin-HRP solution was added to each well, and the plate was returned to the shaker 
for another 30 minutes.  Another wash step was completed as before, and 100 µL 
chromogen solution (TMB) was added to each well.  The plate was then incubated for 10 
minutes in the dark, before applying 100 µL of the provided stop solution.    
 Using a commercially available ELISA microplate reader (BioTek Synergy HT), the 
completed assay was measured for absorbance at 450 nm, and blanked against the control 
well.  Afterward, samples were individually transferred to polystyrene cuvettes that were 
placed in a cuvette holder fixed permanently in the optical path to minimize variation due 
to geometric inconsistencies.  A cuvette filled with 200 µL deionized water was used to 
normalize the RGB intensity values during image post-processing.   
 After data processing, the captured images were converted to absorption spectra that 
show clear concentration dependence across a range of wavelengths from 400 to 550 nm.  
From these spectra, either single wavelength measurements, akin to a microplate reader, or 
integrative absorption measurements can be calculated.  After digital data analysis, IL-6 
concentrations were observed to follow a sigmoidal dose-response curve, as expected 
(Figure 5).  From the data collected, it can be observed that the smartphone-based 
absorption at 450 nm replicates the microplate reader measurements throughout the entire 
range of concentrations, validating our instrument as a portable, low-cost alternative to 
traditional benchtop apparatus.  The integrative absorption has the same characteristic 
shape, and has a comparable Limit of Detection (LOD) lower than the minimum assayed 
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concentration of .25 pg/ml.  Validation of these techniques using the results from the 
traditional microplate reader via Bland-Altman analysis are discussed in Section 3.6. 
3.5 Peanut Allergy Detection 
 The Ara group of peanut proteins consist of those that elicit allergic responses.  
While the specific proteins that an individual might be allergic to might vary, between 70 
% and 90 % of individuals allergic to peanut  products produce an immune response to the 
Microplate Reader Smartphone Absorption at 450 nm
Smartphone Integrative Absorption
Figure 5. Concentration Dependence of Human IL-6. Samples were measured by an ELISA microplate reader, and 
then transferred to cuvettes to be measured by the smartphone instrument.  Concentrations ranging from 0.25 pg/mL 
to 125 pg/mL were measured (n=2) along with a 0 pg/mL control (n=3).  Calculations of the data collected by the 
smartphone were completed both at 450 nm, so as to be directly comparable to conventional ELISA data, and as the 
integrative absorption from 410 <λ< 500 nm.  Limits of detection were calculated as three standard deviations above 
the 0 concentration measurement average. 
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proteins Ara h 1, Ara h 2, and Ara h 6, a homolog for Ara h 2.45  In the US, over 1% of the 
population has a self-reported peanut allergy, and this rate seems to be increasing in 
children.46  While many precautions exist to assist those with severe allergies to avoid 
peanut-based products, there is an increasing trend in the number of peanut allergy-related 
hospitalizations each year.47  There is a high potential value in a portable smartphone-based 
test for peanut allergens present in food, but careful quantification is absolutely essential.  
To our knowledge, this work presents the first proof-of-concept of a portable peanut assay 
that is capable of measuring peanut at concentrations less than the smallest measured No 
Observed Adverse Effect Levels (NOAELs).   
 A commercially available ELISA kit was purchased (R-Biopharm) for the 
quantification of peanut allergens Ara h1.  Samples were taken from cookies purchased at 
two local bakeries, Insomnia Cookies and Schnuck’s Grocer, as well as from pre-packaged 
vanilla Oreo® cookies.  Samples were extracted per kit instructions: 1 gram of each cookie 
sample was ground and placed in a solution of extraction buffer diluted from the provided 
10x concentrate.  Extraction was completed at 60oC for 10 minutes, followed by a 10 minute 
centrifugation at 2,500 g.  The supernatant was then incubated, along with calibrated 
concentrations of peanut solution, in 400 µL wells with immobilized anti-Ara h 1 antibodies 
in triplicate.  Enzyme conjugate, chromogen, and stop solutions were then added for 10 
minutes each, with a 3x wash step in between.  The entire process can be completed in 
under an hour.   
 The same preparation protocol developed for the IL-6 assay was again used for the 
Ara h 1 assay.  The spectra were normalized to a water-filled cuvette during post-
processing, and positioning was repeated.  Lasers were used to recalibrate, and samples 
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were measured in a similar fashion.  After digital data analysis, standard Ara h 1 
concentrations were also observed to follow a sigmoidal dose-response curve (Figures 6, 
7).  The limits of detection for the reported peanut assays were between .09 and .56 ppm.  
Once again, comparative validation was completed with a microplate reader via Bland-
Altman analysis (Section 3.6). Samples from peanut-containing cookies were found to have 
absorbances over that of the maximally assayed standard concentration (20 ppm), and so 
Figure 6. Concentration Dependence of Ara h 1.  Samples were measured by an ELISA microplate reader, and then 
transferred to cuvettes to be measured by the smartphone instrument.  Concentrations ranging from 2.5 ppm to 20 ppm 
were measured along with a 0 ppm control (n=3).  Calculations of the data collected by the smartphone were completed 
both at 450 nm, so as to be directly comparable to the output of the ELISA microplate reader data, and as the integrative 
absorption from 410 to 500 nm.  Limits of detection were calculated as three standard deviations above the 0 
concentration measurement average.   
Smartphone Integrative Absorption
Microplate Reader Smartphone Absorption at 450 nm
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could not be quantitatively measured without further dilution.   While neither Insomnia nor 
Schnuck’s claimed that their sugar cookies were safe for consumption by people with 
severe peanut allergies, the sugar cookie from Schnuck’s did, in fact, have an absorbance 
less than the assayed limit of detection (Figure 8).  As expected, prepackaged sandwich 
crackers without a label indicating a risk of nut contamination tested below the assay LOD. 
  
Smartphone Integrative Absorption
Microplate Reader Smartphone Absorption at 450 nm
Figure 7. Second Experiment of the Concentration Dependence of Ara h 1. Samples were measured by a 
conventional microplate reader, and then transferred to cuvettes to be measure by the smartphone biosensor.  
Concentrations ranging from 2.5 ppm to 20 ppm (n=3) were measured along with a 0 pg/mL control (n=5).  
Calculations of the data collected by the smartphone biosensor were completed both at 450 nm, so as to be directly 
comparable to the output of a commercially available ELISA microplate reader data, and as the integrative absorption 
from 410 to 500 nm.  Limits of detection were calculated as three standard deviations above the 0 concentration 
measurement average.   
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Figure 8. Quantification of Ara h 1 in Cookie Samples from Two Local Bakeries. Sample cookies were collected 
and contained separately in plastic to avoid cross-contamination.  Samples were measured, ground, and proteins were 
extracted following manufacturer protocol.  Vanilla Oreo® samples (n=3) and Schnuck’s cookie samples (n=2) were 
assayed with data in Figure 5, and Insomnia cookies were assayed with data in Figure 6 (n=3).  As the cookies were 
run on two different assays, only the higher LOD is shown.   
* Peanut Butter cookies had concentrations of Ara h 1 higher than the maximum assayed standard concentration, so 
significant dilution would be required for accurate quantification. 
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3.6 Comparison of Smartphone Sensitivity and ELISA Microplate Reader 
3.6.1 Comparing Capabilities 
 For each sample measured in the conventional microplate reader, a spectrum was 
generated from a series of 5 collected images.  Both the absorption at λ=450 nm and the 
integrative absorption from λ=410 to 500 nm were calculated.  All data points were fit with 
the same four-parameter logistic model described above.  From the data collected, the 
absorptive LOD from either sensing modality appear to be in rough concordance, whereas 
the LOD obtained using the integrative absorption method is consistently 2-3x lower (Table 
1) than that obtained by considering the absorption of only a single wavelength.  This 
suggests that by taking advantage of the full spectral profile of the absorption peak resulting 
from the chromogen, it is possible to achieve a higher sensitivity than that obtained by 
observing a single wavelength.  The availability of the full spectral absorption information 
also enables the system to easily function with a broad range of chromogens that generate 
different colored solutions.   
 ELISA 
Microplate 
reader 
Smartphone 
Absorption at 
450nm 
Smartphone     
Integrative 
Absorption 
Experiment 1 0.314 ppm 0.268 ppm 0.107 ppm 
Experiment 2 0.529 ppm 0.560 ppm 0.269 ppm 
 
Table 1. Comparison of detection limits of the Ara h 1 ELISA microplate reader, smartphone absorption at 
λ=450nm, and smartphone integrative absorption 
 
3.6.2 Analyzing Agreement of Measurement Techniques 
 In the realm of clinical medicine, the appearance of agreement between 
measurement techniques is not sufficient to support the adoption of a new instrument.  In 
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the field of diagnostics, understanding the agreement between the new device and the 
current gold-standard is both important and non-trivial.  Recognizing that even gold-
standard techniques have inherent measurement uncertainty, a simple correlation analysis 
will not accurately reflect the combined uncertainties.  To address this issue, Bland and 
Altman developed a methodology that has become widely accepted as a viable technique, 
based upon the average measurements of the two techniques and the absolute differences 
at those averages.48 
 As ELISA absorbance measurements often have a lognormal distribution, a 
variation on the standard method using the geometric mean and log difference was applied 
to all non-zero values for each assay (Figure 9).48-50 The log differences showed a 
Figure 9. Validation of Smartphone Measurement Technique versus Microplate Reader via Bland-Altman 
Analysis.  The lognormal quality of ELISA absorbances dictated the use of the geometric mean vs. log difference 
plot shown.  All nonzero points are plotted, with the dashed line being the mean of the primary linear regression.  
Solid lines represent the 95% confidence limits of agreement, which contain all but one data point across the three 
separate experiments.   
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dependence on the magnitude of the measurement, so a regressive approach was used to 
model the relation so appropriate limits of agreement could be attained.51  The regression 
was modeled as  
  ?̂? = 𝑏0 + 𝑏1?̂? (Eq. 3.2) 
where ?̂? is the vector of the geometric means of the two measurement techniques, ?̂? is the 
vector of absolute log differences, and b0 and b1 are the intercept and slope, respectively.  
For all three experiments, this provided a viable fit for the data; however, it was still 
necessary to see if the dependence on measurement magnitude continues into the residuals 
which are given by  
  𝑟 = 𝑐0 + 𝑐1𝑥 (Eq. 3.3) 
where r is the vector of residuals, and c0 and c1 are the slope and intercept for the residual 
regression.  The R2 value for the IL-6 assay residuals was significant at .224, while the 
values for the two Ara h 1 experiments were between .02 and .06.  As the relationship 
between the residuals and magnitude of the measurement was found to be significant in at 
least one of the experiments, the model of the residuals was combined with the first model 
to provide the 95% limits of agreement.  Assuming that these residuals follow a normal 
distribution, the limits of agreement can be calculated by combining Equations 3.2 and 3.3 
as discussed by Altman:52 
  𝑎1̂, 𝑎2̂ = 𝑏0 + 𝑏1?̂?  ± √𝜋/2 ∗ (𝑐0 + 𝑐1?̂?) (Eq. 3.4) 
where a1 and a2 are the 95% limits of agreement.  Of all data points assayed, only one point 
was found to be outside the ±1.96 S. D. limits of agreement (solid lines).  These data 
demonstrate a high level of consistency between the conventional ELISA microplate reader 
and the smartphone-based spectroscopic absorbance measurements.   
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3.7 Discussion 
 The diagnostic potential for biomarkers such as IL-6 is significant.  Tracking the 
post-operative serum levels of biomolecules to assess the chances of post-operative 
complications could potentially increase positive outcomes for those patients via early-
detection,40 and decrease required post-operative in-hospital recovery time.  While long-
term monitoring of biomarkers could likely provide valuable prognostic information, the 
associated load on hospitals and diagnostic laboratory facilities make any such testing at 
best expensive, and at worst, unrealistic.  Similarly, the measurement of cancer-related 
biomarkers might prove a useful tracking mechanism for potential relapse or metastatic 
risk.53  The development of a cheap yet reliable ELISA reader could facilitate the 
development of a broadly available test in clinic-type environments.   
 In contrast with medical diagnostic assays, allergen detection provides a consumer-
based testing opportunity.  While existing microplate readers are prohibitively expensive 
for individuals and designed specifically for laboratory settings, a handheld smartphone 
attachment is naturally amenable to an in-home testing environment.  Though ELISA 
assays require multiple liquid-handling steps, there have already been several successful 
demonstrations of ELISA performed as a lab-on-a-chip technique that could be integrated 
into a low cost, disposable cartridge, readily read by an instrument such as the one described 
here.  While significant work has gone into simplifying both the sample collection process 
and the liquid handling steps used in a traditional ELISA test, there is still a need for an 
instrument that can replicate the accuracy and repeatability of a microplate reader in a point-
of-care system. 
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 Current alternatives for assay readout are based on either visual inspection or non-
spectral image analysis, neither of which provide the spectral resolution of traditional 
microplate readers.  ELISA testing is dependent on this spectral resolution, as the 
chromogens that are being measured are characterized by non-uniform absorption spectra 
in the visible range. Non-spectral methods of color analysis are subject to the variations in 
intensity present across various wavelengths, usually binned into three RGB channels via 
a Bayer filter.  By diffracting the wavelength of transmitted light along one of the physical 
dimensions of the CMOS sensor, we are able to separate the intensity information of the 
absorbed light from its wavelength, thereby allowing for the wavelength-specific 
quantification of chromogenic absorption.  Furthermore, our technique is broadly 
applicable across all visible wavelengths of the spectrum, even in regions where RGB 
channels sometimes overlap, including both 450 and 492 nm, wavelengths where the 
important ELISA chromogens TMB and OPD maximally absorb, and where RGB analysis 
cannot suffice.    
    While there is general consensus on the importance of minimizing peanut material 
in non-peanut-containing foods, surprisingly little work has been done to quantify the 
amount of peanut protein required to produce an allergic reaction in affected individuals.  
Literature review-based statistical modeling has produced a starting point for such efforts, 
but variations in testing modalities as well as an abundance of situations where NOAELs 
could not be determined due to observed allergic responses at the lowest assayed dosage 
have resulted in a large number of patient results being excluded.54, 55  One of the most 
promising studies of existing data was collected from clinical records of patients being 
tested, rather than from specific patient-recruited studies, which yielded an eliciting dose 
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in 5% of the population (ED5) of 4.2 mg peanut protein.
56  While there is uncertainty in 
some of the numbers prevalent in the literature, the overall range of subjective NOAELs 
reported (or estimated) is typically between .4 and 10 mg protein,56-59 with objective ED5 
have been estimated as low as 1.5 mg.60  For a reasonable maximal daily intake of 500g of 
food based upon a 2000-3000 calorie diet, this would translate to .8 and 3 ppm peanut 
protein for minimum reported NOAEL and ED5, respectively, which are higher than the 
LOD for each of the testing methodologies used.  Thus we have successfully demonstrated 
a point-of-use testing modality that can plausibly be used to measure clinically relevant 
amounts of peanut.   
 While this work has focused upon the demonstration of a liquid-based color 
absorption assay in the context of an ELISA, the approach demonstrated here may be 
applied to any assay that results in the color change of a liquid.  Colorimetric tests are 
relatively common due to their ability to be qualitatively measured via visual inspection.  
Such tests are commonly used in testing liquids for pH, chlorination, and contaminants 
ranging from metals to organic material.  While qualitative information is useful, 
spectroscopic analysis is able to provide quantitative information that is consistent across 
phone manufacturers and independent of operator or hardware-based differences, a 
significant improvement over both visually comparative methods and non-spectrally 
resolved imaging methods.  Broadly, this instrument can perform any such test, assuming 
the absorption spectra exists within the visible range of wavelengths. 
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CHAPTER 4: LABEL-FREE BIODETECTION USING PHOTONIC 
CRYSTAL SENSORS 
4.1 Rationale 
While spectroscopic biological assays such as ELISA can be used for the detection of many 
biological analytes, their widespread adoption into scenarios outside the laboratory is hindered by 
the complexity of the assay protocol which often involves multiple liquid handling steps and 
conjugated antibodies.61-64 Detection of an analyte via one of its intrinsic physical properties 
(dielectric permittivity, mass, conductivity, or Raman scattering spectrum – for example), called 
“label-free” detection,65-67 is preferable for assay simplicity in terms of the number of reagents 
required, washing steps needed, and assay time. 
 Of all the label-free detection approaches that have been demonstrated, those based upon 
optical phenomena have been commercially preferred due to a combination of high sensitivity, 
low sensor cost, detection system robustness, and high throughput capacity.  Adsorption of 
biomolecules, viral particles, bacteria, or cells onto the surface of an optical biosensor transducer 
results in a shift in the conditions of optimal optical coupling, which can be measured by 
illuminating the transducer surface and measuring a property of the reflected or transmitted light.  
Such a detection approach is robust, and has become economically advantageous due to the advent 
of low cost light emitting diodes and semiconductor lasers.  Surface plasmon resonance (SPR) 
based biosensors68-72 and photonic crystal (PC) optical biosensors73-77 are capable of detecting 
broad classes of biological analytes using their intrinsic dielectric permittivity. Each approach has 
been demonstrated using both large laboratory instruments and miniaturized (shoebox-sized) 
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systems. However, no prior label-free optical biosensor instrument has been fully integrated with 
a smartphone, using the onboard camera itself as the detection instrument.  
 Here, we demonstrate the use of a smartphone to detect shifts in the resonant wavelength 
of a PC-based label-free biosensor.  PC biosensors are amenable to readout by a smartphone, as 
they function as narrow bandwidth reflection filters that can be measured by illuminating them at 
normal incidence with collimated white light. The PC used in this work was designed to produce 
a high efficiency resonant reflection at a wavelength in the visible spectrum (λ= 565 nm) in air. 
Adsorption of biomolecules on the PC surface results in a red-shift of the resonant peak. To enable 
the rear-facing smartphone camera to measure this resonant peak, we use a setup very similar to 
that used for absorption measurements. While the phone and the optical components are held in 
position, the PC sensor itself may be inserted and removed from a narrow slot within the cradle. 
Importantly, the system incorporates the ability to compare wavelength shifts from adjacent 
“active” and “reference” regions of the PC as a means for incorporating an accurate experimental 
control. To demonstrate operation of this sensor and detection system, we will analyse the 
concentration dependence of the Protein A-porcine IgG interaction.   
4.2 Background on Photonic Crystals 
Photonic crystals (PCs) comprise a broad class of optical structures that are composed of a 
subwavelength periodic modulation of refractive index.  While these modulations have been 
demonstrated in two and three-dimensional structures, this thesis will focus on specific 
applications of the simplest case: the 1-dimensional periodic grating. 
As described in previous publications,78, 79 these gratings can be easily manufactured via 
nanoreplica molding in a UV-curable polymer on a disposable plastic substrate.  Upon curing, this 
then provides a grating structure of the desired height, width, and period over which subsequent 
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depositions of specific thicknesses of dielectrics can be made.  For these experiments, SiO2 and 
TiO2 were used for low- and high-refractive index materials, respectively.   
When collimated light is incident on the grating structure, a portion of the light is diffracted 
by the high-refractive index TiO2 layer in a wavelength- and angle-dependent manner, according 
to the grating equation: 
 Λ(sin(𝜃𝑖) − sin(𝜃𝑑)) = 𝑛𝜆 (Eq. 4.1) 
where Λ is the grating period, 𝑛 is the diffraction order, 𝜆 is the wavelength of light, and 𝜃𝑖 and 𝜃𝑑 
are the incident and diffracted angles, respectively.  Much of the light passes through without 
diffraction (𝑛 = 0), but some of the light undergoes first-order diffraction, which at normal 
incidence conveniently simplifies to  
 sin(𝜃𝑑) = −
𝜆
Λ
 (Eq. 4.2). 
Periodic waveguides such as this have been shown to have a specific resonance condition where 
the first-order diffracted light propagates as a guided mode due to total internal reflection when  
 2𝑘3𝑑 + 2Φ1,2 + 2Φ2,3 = 2𝜋𝑚 (Eq. 4.3) 
where 𝑘3 = 2𝜋/𝜆  is the wavevector of the light perpendicular to the grating in the SiO2, 𝑑 is the 
thickness of the grating, m is the order of diffraction and Φ1,2 and Φ2,3 are the Fresnel coefficients 
due to differences in refractive index between the waveguide (SiO2) and surrounding layers.
80 At 
each interface of the waveguide that the internally refracted light hits, a portion of the light is 
refracted back out of the grating.  Light that undergoes two instances of internal refraction before 
escaping the grating is angularly aligned with light that simply passed through the grating, but it 
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has undergone a phase shift relative to its non-diffracted counterpart, resultant from the Fresnel 
coefficients of reflection and diffraction and the difference in path length, which is given by  
 Φ = 2𝑘3𝑑 + 2Φ1,2 + 2Φ2,3 + 𝜋 (Eq. 4.4) 
It is important to note that this path length difference results in the twice-reflected and non-
reflected light being exactly 𝜋 out of phase, yielding complete destructive interference.81  
Similarly, light that undergoes a single internal refraction before escaping the waveguide can be 
shown to completely constructively interfere, yielding effectively 100% reflection.   
 Assuming constant perpendicular illumination, the only factors that affect this resonant 
wavelength are the Fresnel coefficients, which are dependent on the relative refractive indices of 
the grating and waveguide layers.  As biomolecules attach to the exposed surface of the PC, the 
effective refractive index of the TiO2 is slowly increased in a quantifiable manner, which serves 
as the foundation for label-free quantification of biomolecular attachment (Figure 10).  The 
Cunningham group has utilized this technique for a variety of analytes, including pancreatic cancer 
cytotoxicity screenings,82 the presence of porcine rotavirus in biological samples,83 and HIV viral 
load.84 
4.3 PC Characteristics for Smartphone Biosensing 
 For these experiments, a one-dimensional grating structure was created on a disposable 
plastic substrate in UV-curable polymer via nanoreplica molding.  As depicted in Figure 10, the 
PC grating period was 360 nm and the depth was 60 nm.  The polymer grating was subsequently 
over-coated with sputtered thin films of SiO2 (t = 200 nm, refractive index = 1.54) and TiO2 (t = 
60 nm, refractive index = 2.35).  After fabrication, the flexible plastic substrates were attached to 
standard 25 by 75 mm glass slides using double-sided, pressure-activated adhesive film. The 
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grating dimensions and thin film thicknesses were designed to provide a 95% efficient narrowband 
reflectance with a central wavelength of λ = 565 nm and a resonance bandwidth (full width at half-
maximum: FWHM) of λ ~5 nm when the surface of the PC is dry. Adsorption of biochemical 
molecules onto the surface of the PC results in an increase of the effective refractive index of the 
high refractive index waveguide layer, yielding a positive shift in the peak wavelength value 
(PWV) of the narrowband maximum of reflection efficiency (measured as a minimum in 
transmission efficiency by the smartphone).85 The magnitude of this shift can be directly correlated 
to the quantity of IgG present on the PC surface.  
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Figure 10. A. The nanopatterned PC biosensor surface is functionalized via PVA and gluteraldehyde surface 
chemistry to facilitate the capture of IgG molecules.    B. The associated PWV undergoes a red-shift when antibodies 
attach to the surface and increase the effective refractive index of the TiO2 layer. 
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4.4 Measurement Protocol 
To perform a label-free biological assay, the PC is initially prepared by immobilizing a 
capture molecule (such as an antibody, aptamer, or single-strand DNA sequence) that selectively 
recognizes the analyte in a test sample. The sensor surface is further prepared with a “blocking” 
step that prevents nonspecific adsorption of other molecules. The PWV of the sensor is measured 
prior to the addition of the target analyte to establish a baseline reading. Exposure of the sensor to 
the test sample results in adsorption of the analyte on the PC, which is followed by rinsing/drying 
the sensor to remove unbound molecules. A second PWV measurement is then taken and the 
difference in PWV is recorded as the shift due to the adsorption. The basic approach outlined in 
this protocol can be augmented by the incorporation of positive and negative experimental 
controls, including the use of a “reference” sensor that is prepared with an unmatched capture 
molecule, but still exposed to the test sample. Although all measurements reported here were taken 
with the PC surface in a dry state, the system could be further modified via the incorporation of a 
static liquid chamber or flow cell with the PC, so that the PWV shifts can be monitored kinetically. 
4.5 PC-based Biodetection with a Smartphone 
To demonstrate the ability of the sensor and detection instrument to perform a biodetection 
assay in which a layer of immobilized capture molecule is able to selectively capture a specific 
biomolecule of interest, we captured porcine immunoglobulin G (IgG) using an immobilized layer 
of Protein A.  While not in the realm of the biotin-streptavidin interaction, Protein A/G-antibody 
reactions are some of the stronger interactions observed in physiological conditions. 
 To begin, the PC sensor was functionalized with an aldehyde-based surface chemistry to 
facilitate the attachment of Protein A.  To prepare the surface for functionalization, the PC slide 
was thoroughly cleaned using an acetone/IPA/DI-H2O wash, and then functionalized with a 10% 
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solution of polyvinylamine in water at 40o C for two hours. It was then washed 3x in ultrapure 
water, and incubated in a 25% solution of glutaraldehyde in water (Sigma Aldrich) for 4 hours at 
room temperature.  After a subsequent 3x wash in ultrapure water and drying of the sensor surface, 
the PWV from 14 distinct locations on the functionalized PC surface were recorded by the 
smartphone detection instrument to establish the baseline PWV upon which subsequent 
wavelength shifts caused by the attachment of capture and target molecules would be compared. 
 Next, a custom-made polydimethylsiloxane (PDMS) gasket was adhered to the PC sensor 
surface to form 14 separate assay wells (diameter = 6 mm) over the 14 measurement locations.  
Each well was incubated with 60 μL of 0.5 mg/mL Protein A in .01M phosphate buffered solution 
(PBS; pH= 7.4) for 20 minutes. After Protein A immobilization, the wells were washed with PBS, 
the gasket was removed, and the PC sensor was dried.  A second PWV reading was gathered from 
each location, in order to establish the PWV shift due solely to the attachment of the Protein A 
layer.  Figure 11 A shows the initial PWV associated with each of the 14 wells on a single PC 
sensor, and the PWV shift induced at each location by Protein A deposition, demonstrating the 
initial variability induced by the PC functionalization (average PWV = 561.99 nm, stdev = 0.464 
Figure 11. Concentration dependent PWV shift of porcine IgG antibody. A. Variation in slide functionalization 
versus Protein A deposition. B. Protein A was immobilized on two PC sensors to detect concentrations of porcine IgG 
antibody present in quantities between 1 nM and 5000 nM. N = 3 for assay wells; N = 2 for control wells. 
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nm), and the PWV shift induced by the Protein A deposition process (average ΔPWV= 1.46 nm, 
stdev = 0.288 nm).  These results demonstrate that the surface chemistry for protein attachment 
used here introduces a greater degree of variability than the variability of the subsequently 
observed sensor measurements from the smartphone instrument.  
 Prior to the exposure of the PC sensor to the IgG analyte, the gasket was replaced, and the 
PC was rehydrated with 60 μL PBS in each well for 10 minutes.  After aspiration, 60 μL of porcine 
IgG solutions were added to each well at concentrations ranging from 4.25 nM to 3.4 μM (Figure 
11 B) and incubated for 10 minutes.  After a rinse with 0.01 M PBS to remove unbound antibody, 
the PC sensor was dried and measured using the smartphone to calculate the ΔPWV induced by 
IgG attachment.  Concentration-dependent PWV shifts were observed, with each IgG 
concentration being measured in triplicate. Intra-sensor variability is low (average stdev for 
triplicate measurements was 0.335 nm). The lowest IgG concentration tested (4.25 nM) was 
observable above the negative control (0 nM IgG), indicating the ability to clearly measure 
wavelength shifts of 0.16 nm above sensor-specific background noise on that sensor (data not 
shown) that is limited by assay-related variability, rather than by the wavelength shift resolution 
of the detection instrument.  Despite its compact size and simplicity, the detection instrument is 
capable of detecting the presence of analytes in the nM concentration range with a “direct” assay.  
The limits of detection of the system can be reduced further through the use of a variety of tags, 
such as secondary antibodies86 or nanoparticles87, 88 that can amplify the wavelength shift by 
factors of 5 - 1000 x. 
4.6 Discussion 
 For the practical utility of the apparatus, it is important for future versions of the 
smartphone biosensor to have the ability to use wet samples by allowing for the use of thicker 
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cartridges comprised of 3D wells, as opposed to the current methodology of current limitation of 
working with planar slides.  The decision to take measurements of the PC surface in a dry state 
was dictated by the desire to measure sensors in as simple of a manner as possible, without the 
possibility for bulk refractive index effects, or the incorporation of fluid flow (with associated 
pumps and valves) into the instrument. Detection in a dry state also allows for the assay steps to 
be performed separately from the detection step in both time and physical location, which would 
be desirable for several of the real-world detection scenarios being considered at that time.  
Incorporation of a microfluidic channel into the sensor through the fabrication of a more 
sophisticated cartridge would enable liquid-based detection and the potential for measuring the 
kinetics of analyte binding without altering the fundamental measurement approach, but was not 
addressed as a part of this thesis. 
 The experiments used to characterize the smartphone detection instrument presented in this 
paper serve to demonstrate the feasibility of measuring PWV shifts from a PC biosensor, rather 
than focusing on the application of the system to complex test samples that contain many 
potentially interfering compounds.  In order to address this issue for such applications, it will be 
necessary to incorporate reference sensors that can serve as negative controls to the effects of 
nonspecific binding. Such methods, commonly reported in the biosensor literature, should include 
multiple types of negative controls. First, as shown in this work, a detection experiment should 
include a sensor that is prepared with the capture molecule, but that is exposed to buffer rather 
than to the test sample. Secondly, the experiment should also include a sensor that is prepared with 
a capture molecule that does not recognize the analyte (such as an antibody for a nonrelated 
antigen), and exposed to the test sample.  The combination of these two experimental controls can 
determine the mass density of analyte molecules that are bound nonspecifically to the sensor 
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surface from a complex media, while at the same time taking into account common mode error 
sources such as temperature variability or bulk refractive index variability.  
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CHAPTER 5: CONCLUSION 
 In this manuscript, we have demonstrated two usage cases for a novel smartphone-based 
spectrometer: absorption measurements for use with standard ELISA procedures, and PWV 
measurements for use with photonic crystal based label-free assays.  The need for POCT that can 
transfer traditional laboratory assays to primary care settings is significant both domestically and 
globally. 
 In the first part of this thesis we describe the successful detection of human IL-6, an 
important cancer biomarker, and Ara h 1, one of the principle peanut proteins responsible for 
causing a reaction.  Limits of detection were found to be as low as those from the standard 
microplate reader, and the high level of agreement between the two sensing methods was 
demonstrated via Bland-Altman analysis.  Finally, cookies from two local bakeries were tested for 
cross-contamination with peanut ingredients, and the instrument was demonstrated as a practical 
tool for detecting clinically relevant concentrations of allergen.   
 In the latter half of the work,  the instrument was modified to provide polarized light which 
could be used to illuminate a photonic crystal at its resonance condition, providing a narrowband 
reflection phenomenon that redshifts as biomolecular adsorption takes place on the PC surface.  
As demonstration of its biological utility, the concentration dependence of the Protein A-IgG 
interaction was investigated.  Concentrations of less than 1 µg/mL were successfully quantified.   
5.1 Future Directions 
 The experiments described in this manuscript are primarily point-of-concept exercises.  
Significant improvement can be made upon the techniques used in areas ranging from sample 
preparation to on-board automation.  Many of these ancillary improvements have been investigated 
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in the literature, as mentioned previously, and compliment the sensing device we have developed.  
Eventually a microfluidic device will be created that will take advantage of these advances, 
providing an assay experience much closer to that which a clinician is looking for, in comparison 
with these first-generation proof-of-concept experiments.   
5.1.1 Developing Other Modalities 
 Absorption measurements comprise a large portion of the canonical optical diagnostic 
methodologies.  PC-based techniques are significantly further behind in development, but offer 
several key benefits, namely the simplification of assay protocol due to their label-free nature.  In 
between the two, though, sits an important body of work within the realm of optical biosensing 
that should be mentioned: fluorescence-based assays.  There are a handful of interesting and useful 
diagnostic tests that can be completed with the use of fluorescent reporter probes including Förster 
resonant energy transfer, fluorescent lifetime, molecular beacon, and fluorescent polarization 
assays.  This modality is readily integrated with our prototype system via augmentation with a few 
external pieces on an optical bench.  Initial tests have already been run showing that such a system 
is feasible on a smartphone platform, but additional work needs to be done to characterize the 
sensitivity of the instrument.  One of the principle requirements of any fluorescent assay is the 
orthogonal illumination of the sample to minimize noise due to the light source in the fluorescent 
signal.  With this modification, new types of assays can be added to those demonstrated here, 
further expanding the capabilities that the instrument can provide in a point-of-care environment.   
5.1.2 Combination of Modalities into a Single Instrument 
While expanding capabilities is important, ease-of-use and simplicity of design are two of 
the most important attributes for a POCT device.  If a single instrument could be used without 
significant modification for absorbance, fluorescence, and PC-based measurements, this would 
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provide an even greater benefit for clinicians.  In addition to simplicity of use, it would decrease 
the costs associated with the testing and decrease the amount of equipment that must be 
transported. 
To this end, a second generation prototype is currently being designed as the first step 
toward a multi-modal optical attachment.  This device will be able to accommodate both 
fluorescent and absorption measurements by using fiber optics to direct light paths internally, and 
will be created via stereolithography (SLA) to allow for continued optimization of optical distances 
once the prototype is functional.  The flexibility provided by SLA technique will also make it 
possible to empirically test the feasibility of a PC-based measurement on the same setup and 
investigate the tradeoff between spectral resolution and illumination strength.   
5.2 Anticipated Challenges 
 Providing a unified system that is capable of performing absorbance, PWV, and 
fluorescent-based measurements without modification presents a significant technical challenge.  
Each of the individual modalities possess its own optimal operational conditions.  Absorption 
measurements require high-intensity illumination, while PWV shifts require high spectral 
resolution.  These two characteristics are both dependent on the diameter of the pinhole used in 
the design, and so careful consideration must be attributed to this design choice.   
 Similarly, developing a system that is broadly applicable across smartphone handsets will 
prove difficult.  While there is some observational evidence that handset manufacturers are 
converging on standard camera placement, the current variety, as well as dimensional variation, 
poses a significant challenge to large-scale adoption of the technology.  While SLA provides a 
simple solution for low production volumes, high-volumes are often created via injection molding.  
To address this, the current approach is to focus on a single handset to develop the technology.  
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Additional options, such as the inclusion of an off-board CMOS chip connected via USB, will be 
investigated with future work. 
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